Stand up for our most vulnerable Americans! Protect Medicare drug benefits.

Now more than ever, we need to make access to quality, affordable health care our number one priority.

The ongoing COVID-19 pandemic reinforces the need to safeguard essential programs like Medicare, Medicaid, and the Affordable Care Act that have extended health coverage to America's most vulnerable populations — seniors, people with disabilities or chronic conditions, and people with low incomes — many of whom lack the resources and platform to fight back against rising health care costs.

We urge Congress and the Biden Administration to reject the flawed policies of the Trump Administration and adopt common-sense reforms that make health care more affordable, reduce out-of-pocket costs for prescription drugs, and protect and safeguard Medicare, Medicaid, and the ACA.

Tell Washington: Stand up for our most vulnerable Americans.
Subject: Protect and safeguard Medicare drug benefits

Dear [Decisionmakers].

The quality of health care in America hinges on our commitment to improving and safeguarding vital programs like Medicare, Medicaid, and the Affordable Care Act. The first 100 days of the Biden Administration will set the tone for access to health care to the country's most vulnerable populations. Under the new Biden Administration, we need to prioritize policies that improve affordability and spur innovative research and development of new life-saving medicines.

In coordination with the Department of Health and Human Services, our representatives must put an end to President Trump's Most Favored Nation policy, which would disproportionately hurt patients with severe illnesses and disabilities by relying on discriminatory quality-adjusted life year assessments that negatively impact seniors.

President Biden should reverse the Centers for Medicare and Medicaid Innovation (CMMI) proposal under the Trump Administration that would allow participating Medicare plans to not cover all drugs in the six protected classes. The six protected classes under Medicare Part D - immunosuppressants, antidepressants, antipsychotics, anticonvulsants, antiretrovirals, and antineoplastics - ensure access to all treatments for epilepsy, cancer, chronic conditions, HIV, and mental illness. The changes in the model drastically reduce the medication options available to Medicare beneficiaries, even forcing patients stable on therapy to change their treatment plans or medications.

I urge Congress to pass comprehensive legislation that limits how much people on Medicare pay for their prescription medications so they can get life-saving medicines without going bankrupt. At the same time Congress should not let other countries determine what drugs Americans should have access to by adopting foreign reference pricing. Any reforms to pricing mechanisms should result in direct reductions where patients feel it most: out-of-pocket costs at the pharmacy counter. Congress and the Biden administration should ensure that patients are the ones benefiting from the drug rebates.

I support legislation that not only caps annual out-of-pocket costs in Medicare Part D but also ensures the patient taking the drug benefits from the rebates and discounts associated with the drug, and expands the low-income subsidy in Medicare Part D. I also support legislation that eliminates surprise medical bills, and reduces the number of copays we regularly face.

Thank you,

[Your Name]
Sign Petition
Sign Petition
You have JavaScript disabled. Without it, our site might not function properly.

Privacy Policy

By signing, you accept Care2's Terms of Service.
You can unsub at any time here.

Having problems signing this? Let us know.